Streetbeat News

Analyst Ratings

PENN

B of A Securities analyst Shaun Kelley has upgraded PENN Entertainment from Neutral to Buy and increased the price target from $27 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:41 pm

PLTK

Roth MKM analyst Eric Handler has maintained a Neutral rating on Playtika Holding (NASDAQ:PLTK) but has reduced the price target from $11 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:39 pm

AAPL

AI

AMD

AMZN

COIN

DIS

GOOGL

MARA

NFLX

NVDA

PLTR

SHOP

SPY

TSLA

The article provides a technical analysis and commentary on various stocks and cryptocurrencies by MandoTrading. It includes specific price targets and observations on market behavior for assets like Apple, AMD, Amazon, Alphabet, Disney, Marathon Digital Holdings, Shopify, C3.ai, Netflix, Palantir, Coinbase, and the SPDR S&P 500 ETF. It also mentions Tesla, NVIDIA, and Bitcoin, with a focus on upcoming events such as NVIDIA's earnings release. The article promotes MandoTrading's educational content and offers a free newsletter subscription.

Portfolio Pulse from Mando Trading

November 20, 2023 | 2:39 pm

MNST

Roth MKM analyst Sean McGowan has maintained a Neutral rating on Monster Beverage (NASDAQ:MNST) but has lowered the price target from $57 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:34 pm

DOLE

Stephens & Co. analyst Ben Bienvenu has reiterated an Overweight rating on Dole (NYSE:DOLE) and maintained a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:32 pm

MNST

Roth MKM analyst Sean McGowan has maintained a Neutral rating on Monster Beverage (NASDAQ:MNST) and lowered the price target from $57 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:32 pm

IIIV

Charles Nabhan, an analyst at Stephens & Co., has maintained an Overweight rating on i3 Verticals (NASDAQ:IIIV) but reduced the price target from $32 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:31 pm

PTCT

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on PTC Therapeutics (NASDAQ:PTCT) and maintained a price target of $51.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:28 pm

PWP

JMP Securities analyst Devin Ryan has reiterated a 'Market Outperform' rating on Perella Weinberg (NASDAQ:PWP) and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:25 pm

INBX

JMP Securities analyst Reni Benjamin has reiterated a 'Market Outperform' rating on Inhibrx (NASDAQ:INBX) and maintained a price target of $27.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 2:19 pm